Price Target
36.30 -0.25(-0.67%)12/05/2025
Ultragenyx Pharmaceutical Inc. (RARE)
Price Target Summary
Ultragenyx Pharmaceutical Inc. (RARE)
Consensus
| High | Low | Consensus | Median | |
| Consensus | 50.00 | 50.00 | 50.00 | 50.00 |
| vs. Current Price ($) | 13.71 | 13.71 | 13.71 | 13.71 |
| vs. Current Price (%) | 37.76 | 37.76 | 37.76 | 37.76 |
Historical Average Price Target
| Last Month | Last Quarter | Last Year | All Time | |
| Average Price Target | 50.00 | 50.00 | 76.33 | 109.00 |
| vs. Current Price ($) | 13.71 | 13.71 | 40.04 | 72.71 |
| vs. Current Price (%) | 37.76 | 37.76 | 110.30 | 200.32 |
Price Target Summary
- The consensus target of 50.00 implies roughly 37.76% upside from the current price.
- The median target of 50.00 suggests about 37.76% upside versus today’s price.
- The most bullish target sits at 50.00, implying a move of about 37.76% from the current level.
- The most bearish target is 50.00, around 37.76% from today’s price.
- The narrow high–low target spread of 0.00 (~0.00%) suggests relatively strong agreement among analysts.
- Last month’s average target of 50.00 was roughly 37.76% above the current price, signalling earlier upside expectations.
- The stock trades roughly 37.76% below last quarter’s average target of 50.00.
- Compared to last year’s average target of 76.33, the stock is now about 110.30% higher, reflecting a stronger long-term sentiment.
- Against the long-term average target of 109.00, the stock is up roughly 200.32%, highlighting a major shift in market expectations.
Analyst - Price Targets
- The consensus target of 50.00 implies roughly 37.76% upside from the current price.
- The median target of 50.00 suggests about 37.76% upside versus today’s price.
- The most bullish target sits at 50.00, implying a move of about 37.76% from the current level.
- The most bearish target is 50.00, around 37.76% from today’s price.
- The narrow high–low target spread of 0.00 (~0.00%) suggests relatively strong agreement among analysts.
- Last month’s average target of 50.00 was roughly 37.76% above the current price, signalling earlier upside expectations.
- The stock trades roughly 37.76% below last quarter’s average target of 50.00.
- Compared to last year’s average target of 76.33, the stock is now about 110.30% higher, reflecting a stronger long-term sentiment.
- Against the long-term average target of 109.00, the stock is up roughly 200.32%, highlighting a major shift in market expectations.